FDA inspection
CTI Biopharma Corp: FDA inspection ending May 25, 2021
FDA inspection 1143134 · No Action Indicated (NAI) · Seattle, WA
Key facts
| Inspection ID | 1143134 |
|---|---|
| Firm | CTI Biopharma Corp |
| FEI number | 1000135672 |
| Address | 3101 Western Ave Ste 800 |
| City | Seattle |
| State | WA |
| ZIP | 98121 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | May 25, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data